array:23 [
  "pii" => "S2173574320301325"
  "issn" => "21735743"
  "doi" => "10.1016/j.reumae.2020.05.001"
  "estado" => "S300"
  "fechaPublicacion" => "2021-11-01"
  "aid" => "1434"
  "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología"
  "copyrightAnyo" => "2020"
  "documento" => "article"
  "crossmark" => 1
  "subdocumento" => "fla"
  "cita" => "Reumatol Clin. 2021;17:491-3"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:1 [
    "total" => 0
  ]
  "Traduccion" => array:1 [
    "es" => array:19 [
      "pii" => "S1699258X20301340"
      "issn" => "1699258X"
      "doi" => "10.1016/j.reuma.2020.05.006"
      "estado" => "S300"
      "fechaPublicacion" => "2021-11-01"
      "aid" => "1434"
      "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología"
      "documento" => "article"
      "crossmark" => 1
      "subdocumento" => "fla"
      "cita" => "Reumatol Clin. 2021;17:491-3"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:1 [
        "total" => 0
      ]
      "es" => array:12 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Art&#237;culo especial</span>"
        "titulo" => "COVID-19&#58; La visi&#243;n del residente de reumatolog&#237;a"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "tieneResumen" => array:2 [
          0 => "es"
          1 => "en"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "491"
            "paginaFinal" => "493"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "COVID-19&#58; Overview of Rheumatology Fellows"
          ]
        ]
        "contieneResumen" => array:2 [
          "es" => true
          "en" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Andrea Garcia-Guill&#233;n, Sicylle Jeria, David Lobo-Prat, Lu&#237;s Sainz"
            "autores" => array:4 [
              0 => array:2 [
                "nombre" => "Andrea"
                "apellidos" => "Garcia-Guill&#233;n"
              ]
              1 => array:2 [
                "nombre" => "Sicylle"
                "apellidos" => "Jeria"
              ]
              2 => array:2 [
                "nombre" => "David"
                "apellidos" => "Lobo-Prat"
              ]
              3 => array:2 [
                "nombre" => "Lu&#237;s"
                "apellidos" => "Sainz"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S2173574320301325"
          "doi" => "10.1016/j.reumae.2020.05.001"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => false
            "ES2" => false
            "LATM" => false
          ]
          "gratuito" => false
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574320301325?idApp=UINPBA00004M"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X20301340?idApp=UINPBA00004M"
      "url" => "/1699258X/0000001700000009/v1_202110280722/S1699258X20301340/v1_202110280722/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S217357432100071X"
    "issn" => "21735743"
    "doi" => "10.1016/j.reumae.2020.05.007"
    "estado" => "S300"
    "fechaPublicacion" => "2021-11-01"
    "aid" => "1435"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and Sociedad Espa&#241;ola de Reumatolog&#237;a y Colegio Mexicano de Reumatolog&#237;a"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "fla"
    "cita" => "Reumatol Clin. 2021;17:494-8"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:12 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>"
      "titulo" => "Human papilloma virus screening&#58; evaluation of testing and surveillance in rheumatoid arthritis&#44; psoriatic arthritis and systemic lupus erythematosus"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "494"
          "paginaFinal" => "498"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Cribado del virus de papiloma humano&#58; evaluaci&#243;n de grado de vigilancia en artritis reumatoide&#44; artritis psori&#225;sica y lupus eritematoso sist&#233;mico"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Blanca Vidal Alejandre, Ernesto Tovar Sugra&#241;es, Raquel L&#243;pez Poza, Mariano Andr&#233;s, Mar&#237;a Paz Mart&#237;nez-Vidal"
          "autores" => array:5 [
            0 => array:2 [
              "nombre" => "Blanca"
              "apellidos" => "Vidal Alejandre"
            ]
            1 => array:2 [
              "nombre" => "Ernesto"
              "apellidos" => "Tovar Sugra&#241;es"
            ]
            2 => array:2 [
              "nombre" => "Raquel"
              "apellidos" => "L&#243;pez Poza"
            ]
            3 => array:2 [
              "nombre" => "Mariano"
              "apellidos" => "Andr&#233;s"
            ]
            4 => array:2 [
              "nombre" => "Mar&#237;a Paz"
              "apellidos" => "Mart&#237;nez-Vidal"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S1699258X20301352"
        "doi" => "10.1016/j.reuma.2020.05.007"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X20301352?idApp=UINPBA00004M"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S217357432100071X?idApp=UINPBA00004M"
    "url" => "/21735743/0000001700000009/v1_202110300812/S217357432100071X/v1_202110300812/en/main.assets"
  ]
  "en" => array:18 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Special Article</span>"
    "titulo" => "COVID-19&#58; Overview of rheumatology fellows"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "491"
        "paginaFinal" => "493"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Andrea Garcia-Guill&#233;n, Sicylle Jeria, David Lobo-Prat, Lu&#237;s Sainz"
        "autores" => array:4 [
          0 => array:4 [
            "nombre" => "Andrea"
            "apellidos" => "Garcia-Guill&#233;n"
            "email" => array:1 [
              0 => "agarciagui@santpau.cat"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:2 [
            "nombre" => "Sicylle"
            "apellidos" => "Jeria"
          ]
          2 => array:2 [
            "nombre" => "David"
            "apellidos" => "Lobo-Prat"
          ]
          3 => array:2 [
            "nombre" => "Lu&#237;s"
            "apellidos" => "Sainz"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Servei de Reumatologia&#44; Hospital de la Santa Creu i Sant Pau&#44; Barcelona&#44; Spain"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "COVID-19&#58; Lla visi&#243;n del residente de reumatolog&#237;a"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">The 2019 coronavirus disease pandemic &#40;COVID-19&#41; has created an unprecedented global health emergency and has rapidly led to a change in our professional and personal outlook&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">COVID-19 is caused by the new SARS-CoV-2 betacoronavirus&#46; It was initially detected in the city of Wuhan &#40;Hubei&#44; China&#41; in December 2019 and has spread very quickly&#44; with more than 4 million confirmed cases worldwide as of May 11&#44; 2020&#46;<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Spain has been one of the most affected countries&#44; with more than 215&#44;000 confirmed cases and more than 26&#44;000 deaths&#44; according to the most recent data from the Johns Hopkins Coronavirus Resource Center&#46;<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">The high transmission of the virus has led to a rapid spread of the infection&#44; resulting in a high volume of patients requiring hospitalization or intensive care in a very short time&#46; Simultaneously attending to the needs of so many patients&#44; a significant number of them critical&#44; has been a real stress test for the health system of developed countries&#44; with an extremely high demand for resources&#44; beyond those available&#46; To tackle this global health crisis&#44; countries have been forced to take extraordinary measures&#44; including restrictive measures of social distancing and individual protection&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">The role of the rheumatologist in a &#8220;COVID&#8221; hospital</span><p id="par0020" class="elsevierStylePara elsevierViewall">Rheumatologists have experienced this pandemic with particular intensity&#46; Many of our patients are considered at risk of developing serious infections due to their immunosuppressed state&#44; either because of their underlying disease or due to the use of immunosuppressive therapies&#46; However&#44; at present&#44; there is insufficient data to indicate that rheumatology and autoimmune disease patients undergoing immunosuppressive therapy who are infected with SARS-COV-2 have a poorer outcome due to COVID- 19&#46;<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> Furthermore&#44; some of these treatments are being investigated as potential therapies for the disease&#44; including antimalarials&#44; interleukin-6 receptor &#40;IL&#41; inhibitors &#40;IL-6R&#41;&#44; IL-1 inhibitors&#44; or JAK kinase inhibitors&#46; Confirmed data show that a subgroup of infected patients initially develop a phase of viral replication&#44; but subsequently present a process of hyperinflammation as a response&#44; by a severe activation of the immune system &#40;cytokine release syndrome&#41;<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> mediated by different cytokines &#40;IL-1&#44; IL-2&#44; IL-6&#44; IL-7&#44; IL-10&#44; IL-12&#44; interferon-&#947; and TNF -&#945;&#41;&#44; resulting in clinical pictures with high morbidity and mortality&#46;<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> In this sense&#44; the design of selective cytokine &#40;IL-1&#44; I-6R&#41; blocking strategies or the use of JAK kinase inhibitors seems to play an important role in this cytokine release syndrome&#46;<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> The extensive experience in rheumatology with these drugs in chronic inflammatory diseases allows us to suggest their potential beneficial effects in COVID-19 patients&#46;<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">This health emergency has taken us by surprise in a time of apparent well-being and calm and has been a challenge for the health system and for every one of us&#46; Up until the beginning of May&#44; our hospital had diagnosed more than 2093 positive cases by means of PCR or serology&#44; with more than 1383 hospital admissions&#46; Of these&#44; 146 presented complications that required admission to the intensive care unit &#40;ICU&#41;&#46; With the incessant arrival of the first cases our hospital was forced to adapt quickly&#44; drastically changing its organization and even its infrastructure&#44; to become in a short time a COVID hospital&#44; practically entirely occupied by infected patients&#46; In addition to halting the rotations of our specialized health training&#44; elective surgeries were cancelled&#44; all non-essential care activity in outpatient clinics was cancelled&#44; all non-urgent complementary tests were postponed and urgent surgical activity was moved to another centre&#46; To absorb this high demand for care&#44; ICU beds were created in the operating theatres or in the resuscitation area&#44; and hospitalization beds were made available in areas usually devoted to waiting rooms or other purposes&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">As health professionals we have seen our usual routine change radically&#46; The entire Rheumatology team was integrated into COVID-19 teams&#44; made up of specialists from different specialties to provide care in hospital wards and in the emergency department&#46; Routine outpatient care disappeared&#46; When during a conventional year we would made more than 13&#44;000 annual visits&#44; more than 1500 ultrasound scans&#44; and infiltrations and hospital processes during the day&#44; overnight we went on to a telephone format&#46; In parallel&#44; we have maintained team care via email with the support of our nurse practitioner using a dedicated pandemic email address &#40;<a href="http://reumatologiacovid@santpau.cat">reumatologiacovid&#64;santpau&#46;cat</a>&#41;&#46; Due to the knowledge and experience accumulated with our patients and biological therapies&#44; such as IL-6R inhibitors&#44; we rheumatologists have been able to collaborate in a global and integrated approach to the disease and its complications&#46; We have played a key role in the development of the therapeutic protocols of our centre&#46; The different treatment alternatives without a clear scientific basis&#44; following studies carried out in China and Italy&#44; have made it necessary to develop clinical treatment guidelines specific to each hospital&#46; In our case&#44; we opted initially for antiretroviral treatment &#40;Symtuza&#41; which was quickly replaced by a regimen of hydroxychloroquine 400&#8239;mg&#47;12&#8239;h &#40;one day&#41; followed by 200&#8239;mg&#47;12 &#40;four days&#41; &#43; azithromycin 500&#8239;mg&#47;d &#40;three days&#41;&#46; In refractory cases&#44; we chose to use biological therapy&#44; specifically IL-6 receptor blockers &#40;tocilizumab &#91;TCZ&#93; IV in our case&#41; and in isolated cases SC Sarilumab&#46; At the time of writing this editorial&#44; about 120 patients in our centre have been treated with a single dose of IV TCZ&#44; according to the recommendations of the Spanish National Agency of Medicines &#40;AEMPs&#41;&#46; To date&#44; this strategy has proven highly effective&#44; with mortality rates of less than 5&#46;8&#37; &#40;unpublished data&#41;&#46; In addition&#44; a randomized study &#40;TOCOVID NCT04332094&#41; hydroxychloroquine&#8239;&#43;&#8239;azithromycin 500&#8239;mg&#47;day &#40;three days&#41; with an active arm of subcutaneous TCZ 162&#8239;mg x 2 repeated at 24&#8239;h has been initiated&#46; The TOCOVID trial in recruitment phase has 70 patients randomized and results are expected to be published soon&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">COVID-19 disease is multisystemic in nature and therefore requires a multidisciplinary approach&#46; Collaboration between specialists from different settings has made it possible to offer comprehensive care to patients&#46; In this sense&#44; we have also started a study together with the pulmonologists of our centre to determine the role of the lung damage marker Krebs von den Lungen-6 &#40;KL-6&#41; in the stratification of the risk of respiratory complications in infected patients&#46;</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">The Rheumatology Fellow&#58; a further &#8220;expert&#8221; in COVID-19</span><p id="par0040" class="elsevierStylePara elsevierViewall">For rheumatology fellows&#44; this unexpected situation has meant that our training itineraries have been set aside to devote ourselves exclusively to hospitalized COVID patients&#44; accompanied by fellows and assistants from medical and surgical specialties&#46; Being on the front line&#44; we have contributed in every way possible&#44; taking 12&#8239;-h shifts every day for six weeks in the phase of maximum escalation&#44; with the obvious consequent physical and psychological toll&#46; We have been involved in situations that we would never have imagined&#44; accompanying patients and families remotely&#44; making ethically complex decisions and assuming a responsibility unthinkable in relation to our years of training&#46; The uncertainty experienced in relation to a new disease&#44; not only as professionals but also as patients in many cases&#44; has meant we have experienced both sides of the pandemic&#46; The lack of adequate means of protection&#44; the protocols of action that change on a daily basis&#44; the pressure of care due to casualties in the team&#44; the fear of getting sick and the uncertainty about our immediate formative and professional future&#44; have added to a situation of maximum tension with great physical and emotional impact&#46;</p><p id="par0045" class="elsevierStylePara elsevierViewall">Teamwork and comradeship are some of the positive aspects that this health crisis has brought us&#59; definitely the two key elements in facing this challenge&#46; The presence of doctors from different specialties working simultaneously&#44; the joint effort with nursing&#44; pharmacists&#44; psychologists&#44; assistants&#44; hospital porters&#44; administrative&#44; cleaning and maintenance staff has enabled a multidisciplinary and global approach for the patient with COVID-19&#46; Companionship&#44; in this situation that is so complicated at both the professional and the personal level&#44; has given us the strength to carry on day to day&#46;</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Strengths of the health system and the future of specialist care</span><p id="par0050" class="elsevierStylePara elsevierViewall">This pandemic has also shown that a strong health system and ensuring quality care requires both material and human resources&#46; In this aspect&#44; health professionals and in our case rheumatologists&#44; have been on the front line struggling to care for patients in the best possible way&#44; even without adequate protective equipment in many cases and placing our physical safety at risk&#46;</p><p id="par0055" class="elsevierStylePara elsevierViewall">The current healthcare model will undoubtedly require changes to make it more sustainable and minimize exposure risks&#46; In this regard&#44; enormous possibilities are opening up in the field of telemedicine&#46; This care model&#44; using the new information and communication technologies &#40;ICT&#41;&#44; would allow waiting times to be optimised&#44; unnecessary trips to be avoided&#44; improve the flow of visits according to criteria of severity and encourage efficiency-based activity by practitioners&#46; All of which will enable us to provide sustainable and quality care appropriate to the needs of our patients&#46;</p><p id="par0060" class="elsevierStylePara elsevierViewall">Implementing this new model of care effectively is not exempt from organizational&#44; contextual&#44; structural&#44; and economic challenges&#46; The type and percentage of patients that could benefit from this type of care&#44; the infrastructure needed and the most appropriate technological tools to implement it in a cost-efficient way are some of the unknowns we face&#46;</p><p id="par0065" class="elsevierStylePara elsevierViewall">The COVID-19 pandemic has placed the rheumatology community in the spotlight&#44; has given us the opportunity to contribute our experience in the treatment and development of new therapies for these patients and encouraged us to be pioneers in the care of the future&#44; making fundamental changes that will form the basis for a new era of healthcare&#46;</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Conflict of interests</span><p id="par0070" class="elsevierStylePara elsevierViewall">The authors have no conflict of interests to declare&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:10 [
        0 => array:3 [
          "identificador" => "xres1601110"
          "titulo" => "Abstract"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0005"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec1434790"
          "titulo" => "Keywords"
        ]
        2 => array:3 [
          "identificador" => "xres1601111"
          "titulo" => "Resumen"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0010"
            ]
          ]
        ]
        3 => array:2 [
          "identificador" => "xpalclavsec1434791"
          "titulo" => "Palabras clave"
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Introduction"
        ]
        5 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "The role of the rheumatologist in a &#8220;COVID&#8221; hospital"
        ]
        6 => array:2 [
          "identificador" => "sec0015"
          "titulo" => "The Rheumatology Fellow&#58; a further &#8220;expert&#8221; in COVID-19"
        ]
        7 => array:2 [
          "identificador" => "sec0020"
          "titulo" => "Strengths of the health system and the future of specialist care"
        ]
        8 => array:2 [
          "identificador" => "sec0025"
          "titulo" => "Conflict of interests"
        ]
        9 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2020-05-13"
    "fechaAceptado" => "2020-05-21"
    "PalabrasClave" => array:2 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec1434790"
          "palabras" => array:6 [
            0 => "COVID-19"
            1 => "Coronavirus"
            2 => "Pandemic"
            3 => "Resident"
            4 => "Rheumatologists"
            5 => "Biological agents"
          ]
        ]
      ]
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec1434791"
          "palabras" => array:6 [
            0 => "COVID-19"
            1 => "Coronavirus"
            2 => "Pandemia"
            3 => "Residente"
            4 => "Reumat&#243;logos"
            5 => "Biol&#243;gicos"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:2 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">SARS-COV-2 infection has spread worldwide since it originated in December 2019&#44; in Wuhan&#44; China&#46; The pandemic has largely demonstrated the resilience of the world&#39;s health systems and is the greatest health emergency since World War II&#46; There is no single therapeutic approach to the treatment of COVID-19 and the associated immune disorder&#46; The lack of randomised clinical trials &#40;RCTs&#41; has led different countries to tackle the disease based on case series&#44; or from results of observational studies with off-label drugs&#46;</p><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">We as rheumatologists in general&#44; and specifically rheumatology fellows&#44; have been on the front line of the pandemic&#44; modifying our activities and altering our training itinerary&#46; We have attended patients&#44; we have learned about the management of the disease and from our previous experience with drugs for arthritis and giant cell arteritis&#44; we have used these drugs to treat COVID-19&#46;</p></span>"
      ]
      "es" => array:2 [
        "titulo" => "Resumen"
        "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">La infecci&#243;n por SARS-COV-2 se ha extendido por todo el mundo desde diciembre de 2019&#44; en Wuhan&#44; China&#46; La pandemia ha demostrado ampliamente la resistencia de los sistemas de salud mundiales&#44; convirti&#233;ndose en la mayor emergencia sanitaria desde la Segunda Guerra Mundial&#46; No existe un enfoque terap&#233;utico &#250;nico para el tratamiento de COVID-19 y el trastorno inmunitario asociado&#46; La falta de ensayos cl&#237;nicos aleatorizados &#40;ECA&#41; ha llevado a diferentes pa&#237;ses a enfrentar la enfermedad en base a series de casos&#44; o a partir de resultados de estudios observacionales con f&#225;rmacos fuera de ficha t&#233;cnica&#46;</p><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Los reumat&#243;logos en general&#44; y espec&#237;ficamente los residentes&#44; hemos vivido en primera l&#237;nea la pandemia&#44; modificando nuestras actividades y alterando nuestro itinerario formativo&#46; Hemos atendido pacientes&#44; hemos aprendido el manejo y gracias a nuestra experiencia previa en f&#225;rmacos para la artritis o la arteritis de c&#233;lulas gigantes&#44; hemos utilizado estos f&#225;rmacos para tratar la COVID-19&#46;</p></span>"
      ]
    ]
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as&#58; Garcia-Guill&#233;n A&#44; Jeria S&#44; Lobo-Prat D&#44; Sainz LH&#46; COVID-19&#58; La visi&#243;n del residente de reumatolog&#237;a&#46; Reumatol Clin&#46; 2021&#59;17&#58;491&#8211;493&#46;</p>"
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:6 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Coronavirus Disease &#40;COVID-19&#41; Situation Report-111&#46; 11 mayo de 2020&#59; https&#58;&#47;&#47;www&#46;who&#46;int&#47;docs&#47;default-source&#47;coronaviruse&#47;situation-reports&#47;20200510covid-19-sitrep-111&#46;pdf&#63;sfvrsn&#61;1896976f&#95;2 &#91;accessed 11 May 2020&#93;&#46;"
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0010"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Johns Hopkins Coronavirus Resource Center&#46; 11 de mayo de 2020https&#58;&#47;&#47;coronavirus&#46;jhu&#46;edu&#47;map&#46;html &#91;consultada el 11 de Mayo de 2020&#93;&#46;"
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0015"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "COVID-19 infection and rheumatoid arthritis&#58; Faraway&#44; so close&#33;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "E&#46;G&#46; Favalli"
                            1 => "F&#46; Ingegnoli"
                            2 => "O&#46; De Lucia"
                            3 => "G&#46; Cincinelli"
                            4 => "R&#46; Cimaz"
                            5 => "R&#46; Caporali"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.autrev.2020.102523"
                      "Revista" => array:5 [
                        "tituloSerie" => "Autoimmun Rev"
                        "fecha" => "2020"
                        "volumen" => "19"
                        "paginaInicial" => "102523"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32205186"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0020"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "COVID-19&#58; consider cytokine storm syndromes and immunosuppression"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "P&#46; Mehta"
                            1 => "D&#46;F&#46; McAuley"
                            2 => "M&#46; Brown"
                            3 => "E&#46; Sanchez"
                            4 => "R&#46;S&#46; Tattersall"
                            5 => "J&#46;J&#46; Manson"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(20)30628-0"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet"
                        "fecha" => "2020"
                        "volumen" => "395"
                        "paginaInicial" => "1033"
                        "paginaFinal" => "1034"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32192578"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0025"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical features of patients infected with 2019 novel coronavirus in Wuhan&#44; China"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46; Huang"
                            1 => "Y&#46; Wang"
                            2 => "X&#46; Li"
                            3 => "L&#46; Ren"
                            4 => "J&#46; Zhao"
                            5 => "Y&#46; Hu"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(20)30183-5"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet"
                        "fecha" => "2020"
                        "volumen" => "395"
                        "paginaInicial" => "497"
                        "paginaFinal" => "506"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31986264"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Facing the SARS-CoV-2 &#40;COVID-19&#41; outbreak with IL-6R antagonists"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "H&#46; Corominas"
                            1 => "I&#46; Castellv&#237;"
                            2 => "P&#46; Domingo"
                            3 => "J&#46; Casademont"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.5152/eurjrheum.2020.20061"
                      "Revista" => array:2 [
                        "tituloSerie" => "Eur J Rheumatol"
                        "fecha" => "2020"
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/21735743/0000001700000009/v1_202110300812/S2173574320301325/v1_202110300812/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "5793"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Special article"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/21735743/0000001700000009/v1_202110300812/S2173574320301325/v1_202110300812/en/main.pdf?idApp=UINPBA00004M&text.app=https://reumatologiaclinica.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574320301325?idApp=UINPBA00004M"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

Special Article
COVID-19: Overview of rheumatology fellows
COVID-19: Lla visión del residente de reumatología
Andrea Garcia-Guillén
Corresponding author
agarciagui@santpau.cat

Corresponding author.
, Sicylle Jeria, David Lobo-Prat, Luís Sainz
Servei de Reumatologia, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Read
5553
Times
was read the article
1914
Total PDF
3639
Total HTML
Share statistics
 array:23 [
  "pii" => "S2173574320301325"
  "issn" => "21735743"
  "doi" => "10.1016/j.reumae.2020.05.001"
  "estado" => "S300"
  "fechaPublicacion" => "2021-11-01"
  "aid" => "1434"
  "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and Sociedad Espa&#241;ola de Reumatolog&#237;a y Colegio Mexicano de Reumatolog&#237;a"
  "copyrightAnyo" => "2020"
  "documento" => "article"
  "crossmark" => 1
  "subdocumento" => "fla"
  "cita" => "Reumatol Clin. 2021;17:491-3"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:1 [
    "total" => 0
  ]
  "Traduccion" => array:1 [
    "es" => array:19 [
      "pii" => "S1699258X20301340"
      "issn" => "1699258X"
      "doi" => "10.1016/j.reuma.2020.05.006"
      "estado" => "S300"
      "fechaPublicacion" => "2021-11-01"
      "aid" => "1434"
      "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and Sociedad Espa&#241;ola de Reumatolog&#237;a y Colegio Mexicano de Reumatolog&#237;a"
      "documento" => "article"
      "crossmark" => 1
      "subdocumento" => "fla"
      "cita" => "Reumatol Clin. 2021;17:491-3"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:1 [
        "total" => 0
      ]
      "es" => array:12 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Art&#237;culo especial</span>"
        "titulo" => "COVID-19&#58; La visi&#243;n del residente de reumatolog&#237;a"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "tieneResumen" => array:2 [
          0 => "es"
          1 => "en"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "491"
            "paginaFinal" => "493"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "COVID-19&#58; Overview of Rheumatology Fellows"
          ]
        ]
        "contieneResumen" => array:2 [
          "es" => true
          "en" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Andrea Garcia-Guill&#233;n, Sicylle Jeria, David Lobo-Prat, Lu&#237;s Sainz"
            "autores" => array:4 [
              0 => array:2 [
                "nombre" => "Andrea"
                "apellidos" => "Garcia-Guill&#233;n"
              ]
              1 => array:2 [
                "nombre" => "Sicylle"
                "apellidos" => "Jeria"
              ]
              2 => array:2 [
                "nombre" => "David"
                "apellidos" => "Lobo-Prat"
              ]
              3 => array:2 [
                "nombre" => "Lu&#237;s"
                "apellidos" => "Sainz"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S2173574320301325"
          "doi" => "10.1016/j.reumae.2020.05.001"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => false
            "ES2" => false
            "LATM" => false
          ]
          "gratuito" => false
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574320301325?idApp=UINPBA00004M"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X20301340?idApp=UINPBA00004M"
      "url" => "/1699258X/0000001700000009/v1_202110280722/S1699258X20301340/v1_202110280722/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S217357432100071X"
    "issn" => "21735743"
    "doi" => "10.1016/j.reumae.2020.05.007"
    "estado" => "S300"
    "fechaPublicacion" => "2021-11-01"
    "aid" => "1435"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and Sociedad Espa&#241;ola de Reumatolog&#237;a y Colegio Mexicano de Reumatolog&#237;a"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "fla"
    "cita" => "Reumatol Clin. 2021;17:494-8"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:12 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>"
      "titulo" => "Human papilloma virus screening&#58; evaluation of testing and surveillance in rheumatoid arthritis&#44; psoriatic arthritis and systemic lupus erythematosus"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "494"
          "paginaFinal" => "498"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Cribado del virus de papiloma humano&#58; evaluaci&#243;n de grado de vigilancia en artritis reumatoide&#44; artritis psori&#225;sica y lupus eritematoso sist&#233;mico"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Blanca Vidal Alejandre, Ernesto Tovar Sugra&#241;es, Raquel L&#243;pez Poza, Mariano Andr&#233;s, Mar&#237;a Paz Mart&#237;nez-Vidal"
          "autores" => array:5 [
            0 => array:2 [
              "nombre" => "Blanca"
              "apellidos" => "Vidal Alejandre"
            ]
            1 => array:2 [
              "nombre" => "Ernesto"
              "apellidos" => "Tovar Sugra&#241;es"
            ]
            2 => array:2 [
              "nombre" => "Raquel"
              "apellidos" => "L&#243;pez Poza"
            ]
            3 => array:2 [
              "nombre" => "Mariano"
              "apellidos" => "Andr&#233;s"
            ]
            4 => array:2 [
              "nombre" => "Mar&#237;a Paz"
              "apellidos" => "Mart&#237;nez-Vidal"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S1699258X20301352"
        "doi" => "10.1016/j.reuma.2020.05.007"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X20301352?idApp=UINPBA00004M"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S217357432100071X?idApp=UINPBA00004M"
    "url" => "/21735743/0000001700000009/v1_202110300812/S217357432100071X/v1_202110300812/en/main.assets"
  ]
  "en" => array:18 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Special Article</span>"
    "titulo" => "COVID-19&#58; Overview of rheumatology fellows"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "491"
        "paginaFinal" => "493"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Andrea Garcia-Guill&#233;n, Sicylle Jeria, David Lobo-Prat, Lu&#237;s Sainz"
        "autores" => array:4 [
          0 => array:4 [
            "nombre" => "Andrea"
            "apellidos" => "Garcia-Guill&#233;n"
            "email" => array:1 [
              0 => "agarciagui@santpau.cat"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:2 [
            "nombre" => "Sicylle"
            "apellidos" => "Jeria"
          ]
          2 => array:2 [
            "nombre" => "David"
            "apellidos" => "Lobo-Prat"
          ]
          3 => array:2 [
            "nombre" => "Lu&#237;s"
            "apellidos" => "Sainz"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Servei de Reumatologia&#44; Hospital de la Santa Creu i Sant Pau&#44; Barcelona&#44; Spain"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "COVID-19&#58; Lla visi&#243;n del residente de reumatolog&#237;a"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">The 2019 coronavirus disease pandemic &#40;COVID-19&#41; has created an unprecedented global health emergency and has rapidly led to a change in our professional and personal outlook&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">COVID-19 is caused by the new SARS-CoV-2 betacoronavirus&#46; It was initially detected in the city of Wuhan &#40;Hubei&#44; China&#41; in December 2019 and has spread very quickly&#44; with more than 4 million confirmed cases worldwide as of May 11&#44; 2020&#46;<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Spain has been one of the most affected countries&#44; with more than 215&#44;000 confirmed cases and more than 26&#44;000 deaths&#44; according to the most recent data from the Johns Hopkins Coronavirus Resource Center&#46;<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">The high transmission of the virus has led to a rapid spread of the infection&#44; resulting in a high volume of patients requiring hospitalization or intensive care in a very short time&#46; Simultaneously attending to the needs of so many patients&#44; a significant number of them critical&#44; has been a real stress test for the health system of developed countries&#44; with an extremely high demand for resources&#44; beyond those available&#46; To tackle this global health crisis&#44; countries have been forced to take extraordinary measures&#44; including restrictive measures of social distancing and individual protection&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">The role of the rheumatologist in a &#8220;COVID&#8221; hospital</span><p id="par0020" class="elsevierStylePara elsevierViewall">Rheumatologists have experienced this pandemic with particular intensity&#46; Many of our patients are considered at risk of developing serious infections due to their immunosuppressed state&#44; either because of their underlying disease or due to the use of immunosuppressive therapies&#46; However&#44; at present&#44; there is insufficient data to indicate that rheumatology and autoimmune disease patients undergoing immunosuppressive therapy who are infected with SARS-COV-2 have a poorer outcome due to COVID- 19&#46;<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> Furthermore&#44; some of these treatments are being investigated as potential therapies for the disease&#44; including antimalarials&#44; interleukin-6 receptor &#40;IL&#41; inhibitors &#40;IL-6R&#41;&#44; IL-1 inhibitors&#44; or JAK kinase inhibitors&#46; Confirmed data show that a subgroup of infected patients initially develop a phase of viral replication&#44; but subsequently present a process of hyperinflammation as a response&#44; by a severe activation of the immune system &#40;cytokine release syndrome&#41;<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> mediated by different cytokines &#40;IL-1&#44; IL-2&#44; IL-6&#44; IL-7&#44; IL-10&#44; IL-12&#44; interferon-&#947; and TNF -&#945;&#41;&#44; resulting in clinical pictures with high morbidity and mortality&#46;<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> In this sense&#44; the design of selective cytokine &#40;IL-1&#44; I-6R&#41; blocking strategies or the use of JAK kinase inhibitors seems to play an important role in this cytokine release syndrome&#46;<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> The extensive experience in rheumatology with these drugs in chronic inflammatory diseases allows us to suggest their potential beneficial effects in COVID-19 patients&#46;<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">This health emergency has taken us by surprise in a time of apparent well-being and calm and has been a challenge for the health system and for every one of us&#46; Up until the beginning of May&#44; our hospital had diagnosed more than 2093 positive cases by means of PCR or serology&#44; with more than 1383 hospital admissions&#46; Of these&#44; 146 presented complications that required admission to the intensive care unit &#40;ICU&#41;&#46; With the incessant arrival of the first cases our hospital was forced to adapt quickly&#44; drastically changing its organization and even its infrastructure&#44; to become in a short time a COVID hospital&#44; practically entirely occupied by infected patients&#46; In addition to halting the rotations of our specialized health training&#44; elective surgeries were cancelled&#44; all non-essential care activity in outpatient clinics was cancelled&#44; all non-urgent complementary tests were postponed and urgent surgical activity was moved to another centre&#46; To absorb this high demand for care&#44; ICU beds were created in the operating theatres or in the resuscitation area&#44; and hospitalization beds were made available in areas usually devoted to waiting rooms or other purposes&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">As health professionals we have seen our usual routine change radically&#46; The entire Rheumatology team was integrated into COVID-19 teams&#44; made up of specialists from different specialties to provide care in hospital wards and in the emergency department&#46; Routine outpatient care disappeared&#46; When during a conventional year we would made more than 13&#44;000 annual visits&#44; more than 1500 ultrasound scans&#44; and infiltrations and hospital processes during the day&#44; overnight we went on to a telephone format&#46; In parallel&#44; we have maintained team care via email with the support of our nurse practitioner using a dedicated pandemic email address &#40;<a href="http://reumatologiacovid@santpau.cat">reumatologiacovid&#64;santpau&#46;cat</a>&#41;&#46; Due to the knowledge and experience accumulated with our patients and biological therapies&#44; such as IL-6R inhibitors&#44; we rheumatologists have been able to collaborate in a global and integrated approach to the disease and its complications&#46; We have played a key role in the development of the therapeutic protocols of our centre&#46; The different treatment alternatives without a clear scientific basis&#44; following studies carried out in China and Italy&#44; have made it necessary to develop clinical treatment guidelines specific to each hospital&#46; In our case&#44; we opted initially for antiretroviral treatment &#40;Symtuza&#41; which was quickly replaced by a regimen of hydroxychloroquine 400&#8239;mg&#47;12&#8239;h &#40;one day&#41; followed by 200&#8239;mg&#47;12 &#40;four days&#41; &#43; azithromycin 500&#8239;mg&#47;d &#40;three days&#41;&#46; In refractory cases&#44; we chose to use biological therapy&#44; specifically IL-6 receptor blockers &#40;tocilizumab &#91;TCZ&#93; IV in our case&#41; and in isolated cases SC Sarilumab&#46; At the time of writing this editorial&#44; about 120 patients in our centre have been treated with a single dose of IV TCZ&#44; according to the recommendations of the Spanish National Agency of Medicines &#40;AEMPs&#41;&#46; To date&#44; this strategy has proven highly effective&#44; with mortality rates of less than 5&#46;8&#37; &#40;unpublished data&#41;&#46; In addition&#44; a randomized study &#40;TOCOVID NCT04332094&#41; hydroxychloroquine&#8239;&#43;&#8239;azithromycin 500&#8239;mg&#47;day &#40;three days&#41; with an active arm of subcutaneous TCZ 162&#8239;mg x 2 repeated at 24&#8239;h has been initiated&#46; The TOCOVID trial in recruitment phase has 70 patients randomized and results are expected to be published soon&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">COVID-19 disease is multisystemic in nature and therefore requires a multidisciplinary approach&#46; Collaboration between specialists from different settings has made it possible to offer comprehensive care to patients&#46; In this sense&#44; we have also started a study together with the pulmonologists of our centre to determine the role of the lung damage marker Krebs von den Lungen-6 &#40;KL-6&#41; in the stratification of the risk of respiratory complications in infected patients&#46;</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">The Rheumatology Fellow&#58; a further &#8220;expert&#8221; in COVID-19</span><p id="par0040" class="elsevierStylePara elsevierViewall">For rheumatology fellows&#44; this unexpected situation has meant that our training itineraries have been set aside to devote ourselves exclusively to hospitalized COVID patients&#44; accompanied by fellows and assistants from medical and surgical specialties&#46; Being on the front line&#44; we have contributed in every way possible&#44; taking 12&#8239;-h shifts every day for six weeks in the phase of maximum escalation&#44; with the obvious consequent physical and psychological toll&#46; We have been involved in situations that we would never have imagined&#44; accompanying patients and families remotely&#44; making ethically complex decisions and assuming a responsibility unthinkable in relation to our years of training&#46; The uncertainty experienced in relation to a new disease&#44; not only as professionals but also as patients in many cases&#44; has meant we have experienced both sides of the pandemic&#46; The lack of adequate means of protection&#44; the protocols of action that change on a daily basis&#44; the pressure of care due to casualties in the team&#44; the fear of getting sick and the uncertainty about our immediate formative and professional future&#44; have added to a situation of maximum tension with great physical and emotional impact&#46;</p><p id="par0045" class="elsevierStylePara elsevierViewall">Teamwork and comradeship are some of the positive aspects that this health crisis has brought us&#59; definitely the two key elements in facing this challenge&#46; The presence of doctors from different specialties working simultaneously&#44; the joint effort with nursing&#44; pharmacists&#44; psychologists&#44; assistants&#44; hospital porters&#44; administrative&#44; cleaning and maintenance staff has enabled a multidisciplinary and global approach for the patient with COVID-19&#46; Companionship&#44; in this situation that is so complicated at both the professional and the personal level&#44; has given us the strength to carry on day to day&#46;</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Strengths of the health system and the future of specialist care</span><p id="par0050" class="elsevierStylePara elsevierViewall">This pandemic has also shown that a strong health system and ensuring quality care requires both material and human resources&#46; In this aspect&#44; health professionals and in our case rheumatologists&#44; have been on the front line struggling to care for patients in the best possible way&#44; even without adequate protective equipment in many cases and placing our physical safety at risk&#46;</p><p id="par0055" class="elsevierStylePara elsevierViewall">The current healthcare model will undoubtedly require changes to make it more sustainable and minimize exposure risks&#46; In this regard&#44; enormous possibilities are opening up in the field of telemedicine&#46; This care model&#44; using the new information and communication technologies &#40;ICT&#41;&#44; would allow waiting times to be optimised&#44; unnecessary trips to be avoided&#44; improve the flow of visits according to criteria of severity and encourage efficiency-based activity by practitioners&#46; All of which will enable us to provide sustainable and quality care appropriate to the needs of our patients&#46;</p><p id="par0060" class="elsevierStylePara elsevierViewall">Implementing this new model of care effectively is not exempt from organizational&#44; contextual&#44; structural&#44; and economic challenges&#46; The type and percentage of patients that could benefit from this type of care&#44; the infrastructure needed and the most appropriate technological tools to implement it in a cost-efficient way are some of the unknowns we face&#46;</p><p id="par0065" class="elsevierStylePara elsevierViewall">The COVID-19 pandemic has placed the rheumatology community in the spotlight&#44; has given us the opportunity to contribute our experience in the treatment and development of new therapies for these patients and encouraged us to be pioneers in the care of the future&#44; making fundamental changes that will form the basis for a new era of healthcare&#46;</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Conflict of interests</span><p id="par0070" class="elsevierStylePara elsevierViewall">The authors have no conflict of interests to declare&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:10 [
        0 => array:3 [
          "identificador" => "xres1601110"
          "titulo" => "Abstract"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0005"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec1434790"
          "titulo" => "Keywords"
        ]
        2 => array:3 [
          "identificador" => "xres1601111"
          "titulo" => "Resumen"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0010"
            ]
          ]
        ]
        3 => array:2 [
          "identificador" => "xpalclavsec1434791"
          "titulo" => "Palabras clave"
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Introduction"
        ]
        5 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "The role of the rheumatologist in a &#8220;COVID&#8221; hospital"
        ]
        6 => array:2 [
          "identificador" => "sec0015"
          "titulo" => "The Rheumatology Fellow&#58; a further &#8220;expert&#8221; in COVID-19"
        ]
        7 => array:2 [
          "identificador" => "sec0020"
          "titulo" => "Strengths of the health system and the future of specialist care"
        ]
        8 => array:2 [
          "identificador" => "sec0025"
          "titulo" => "Conflict of interests"
        ]
        9 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2020-05-13"
    "fechaAceptado" => "2020-05-21"
    "PalabrasClave" => array:2 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec1434790"
          "palabras" => array:6 [
            0 => "COVID-19"
            1 => "Coronavirus"
            2 => "Pandemic"
            3 => "Resident"
            4 => "Rheumatologists"
            5 => "Biological agents"
          ]
        ]
      ]
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec1434791"
          "palabras" => array:6 [
            0 => "COVID-19"
            1 => "Coronavirus"
            2 => "Pandemia"
            3 => "Residente"
            4 => "Reumat&#243;logos"
            5 => "Biol&#243;gicos"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:2 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">SARS-COV-2 infection has spread worldwide since it originated in December 2019&#44; in Wuhan&#44; China&#46; The pandemic has largely demonstrated the resilience of the world&#39;s health systems and is the greatest health emergency since World War II&#46; There is no single therapeutic approach to the treatment of COVID-19 and the associated immune disorder&#46; The lack of randomised clinical trials &#40;RCTs&#41; has led different countries to tackle the disease based on case series&#44; or from results of observational studies with off-label drugs&#46;</p><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">We as rheumatologists in general&#44; and specifically rheumatology fellows&#44; have been on the front line of the pandemic&#44; modifying our activities and altering our training itinerary&#46; We have attended patients&#44; we have learned about the management of the disease and from our previous experience with drugs for arthritis and giant cell arteritis&#44; we have used these drugs to treat COVID-19&#46;</p></span>"
      ]
      "es" => array:2 [
        "titulo" => "Resumen"
        "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">La infecci&#243;n por SARS-COV-2 se ha extendido por todo el mundo desde diciembre de 2019&#44; en Wuhan&#44; China&#46; La pandemia ha demostrado ampliamente la resistencia de los sistemas de salud mundiales&#44; convirti&#233;ndose en la mayor emergencia sanitaria desde la Segunda Guerra Mundial&#46; No existe un enfoque terap&#233;utico &#250;nico para el tratamiento de COVID-19 y el trastorno inmunitario asociado&#46; La falta de ensayos cl&#237;nicos aleatorizados &#40;ECA&#41; ha llevado a diferentes pa&#237;ses a enfrentar la enfermedad en base a series de casos&#44; o a partir de resultados de estudios observacionales con f&#225;rmacos fuera de ficha t&#233;cnica&#46;</p><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Los reumat&#243;logos en general&#44; y espec&#237;ficamente los residentes&#44; hemos vivido en primera l&#237;nea la pandemia&#44; modificando nuestras actividades y alterando nuestro itinerario formativo&#46; Hemos atendido pacientes&#44; hemos aprendido el manejo y gracias a nuestra experiencia previa en f&#225;rmacos para la artritis o la arteritis de c&#233;lulas gigantes&#44; hemos utilizado estos f&#225;rmacos para tratar la COVID-19&#46;</p></span>"
      ]
    ]
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as&#58; Garcia-Guill&#233;n A&#44; Jeria S&#44; Lobo-Prat D&#44; Sainz LH&#46; COVID-19&#58; La visi&#243;n del residente de reumatolog&#237;a&#46; Reumatol Clin&#46; 2021&#59;17&#58;491&#8211;493&#46;</p>"
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:6 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Coronavirus Disease &#40;COVID-19&#41; Situation Report-111&#46; 11 mayo de 2020&#59; https&#58;&#47;&#47;www&#46;who&#46;int&#47;docs&#47;default-source&#47;coronaviruse&#47;situation-reports&#47;20200510covid-19-sitrep-111&#46;pdf&#63;sfvrsn&#61;1896976f&#95;2 &#91;accessed 11 May 2020&#93;&#46;"
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0010"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Johns Hopkins Coronavirus Resource Center&#46; 11 de mayo de 2020https&#58;&#47;&#47;coronavirus&#46;jhu&#46;edu&#47;map&#46;html &#91;consultada el 11 de Mayo de 2020&#93;&#46;"
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0015"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "COVID-19 infection and rheumatoid arthritis&#58; Faraway&#44; so close&#33;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "E&#46;G&#46; Favalli"
                            1 => "F&#46; Ingegnoli"
                            2 => "O&#46; De Lucia"
                            3 => "G&#46; Cincinelli"
                            4 => "R&#46; Cimaz"
                            5 => "R&#46; Caporali"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.autrev.2020.102523"
                      "Revista" => array:5 [
                        "tituloSerie" => "Autoimmun Rev"
                        "fecha" => "2020"
                        "volumen" => "19"
                        "paginaInicial" => "102523"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32205186"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0020"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "COVID-19&#58; consider cytokine storm syndromes and immunosuppression"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "P&#46; Mehta"
                            1 => "D&#46;F&#46; McAuley"
                            2 => "M&#46; Brown"
                            3 => "E&#46; Sanchez"
                            4 => "R&#46;S&#46; Tattersall"
                            5 => "J&#46;J&#46; Manson"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(20)30628-0"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet"
                        "fecha" => "2020"
                        "volumen" => "395"
                        "paginaInicial" => "1033"
                        "paginaFinal" => "1034"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32192578"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0025"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical features of patients infected with 2019 novel coronavirus in Wuhan&#44; China"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46; Huang"
                            1 => "Y&#46; Wang"
                            2 => "X&#46; Li"
                            3 => "L&#46; Ren"
                            4 => "J&#46; Zhao"
                            5 => "Y&#46; Hu"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(20)30183-5"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet"
                        "fecha" => "2020"
                        "volumen" => "395"
                        "paginaInicial" => "497"
                        "paginaFinal" => "506"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31986264"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Facing the SARS-CoV-2 &#40;COVID-19&#41; outbreak with IL-6R antagonists"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "H&#46; Corominas"
                            1 => "I&#46; Castellv&#237;"
                            2 => "P&#46; Domingo"
                            3 => "J&#46; Casademont"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.5152/eurjrheum.2020.20061"
                      "Revista" => array:2 [
                        "tituloSerie" => "Eur J Rheumatol"
                        "fecha" => "2020"
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/21735743/0000001700000009/v1_202110300812/S2173574320301325/v1_202110300812/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "5793"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Special article"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/21735743/0000001700000009/v1_202110300812/S2173574320301325/v1_202110300812/en/main.pdf?idApp=UINPBA00004M&text.app=https://reumatologiaclinica.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574320301325?idApp=UINPBA00004M"
]
Article information
ISSN: 21735743
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 4 4 8
2024 October 38 21 59
2024 September 60 17 77
2024 August 84 34 118
2024 July 97 30 127
2024 June 73 28 101
2024 May 78 19 97
2024 April 74 35 109
2024 March 88 786 874
2024 February 74 30 104
2024 January 50 24 74
2023 December 39 30 69
2023 November 78 43 121
2023 October 51 24 75
2023 September 97 48 145
2023 August 101 14 115
2023 July 90 24 114
2023 June 69 31 100
2023 May 54 27 81
2023 April 68 13 81
2023 March 69 35 104
2023 February 82 36 118
2023 January 68 24 92
2022 December 82 69 151
2022 November 97 43 140
2022 October 97 44 141
2022 September 84 50 134
2022 August 94 29 123
2022 July 84 53 137
2022 June 95 48 143
2022 May 105 52 157
2022 April 57 9 66
2022 March 65 9 74
2022 February 117 5 122
2022 January 216 4 220
2021 December 232 3 235
2021 November 41 5 46
2021 October 23 1 24
2021 September 21 4 25
2021 August 22 6 28
2021 July 28 3 31
2021 June 28 7 35
2021 May 46 2 48
2021 April 118 15 133
2021 March 53 7 60
2021 February 33 6 39
2021 January 56 13 69
2020 December 51 16 67
2020 November 51 19 70
2020 October 57 15 72
Show all

Follow this link to access the full text of the article

Idiomas
Reumatología Clínica (English Edition)
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?